Acadia Healthcare Company, Inc. (ACHC)
USD 29.12
(-2.51%)
USD 29.12
(-2.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.34 Billion USD | -9.35% |
| 2022 | 1.48 Billion USD | -7.18% |
| 2021 | 1.59 Billion USD | -47.74% |
| 2020 | 3.05 Billion USD | -15.38% |
| 2019 | 3.6 Billion USD | 14.19% |
| 2018 | 3.15 Billion USD | -1.43% |
| 2017 | 3.2 Billion USD | -1.47% |
| 2016 | 3.25 Billion USD | 48.17% |
| 2015 | 2.19 Billion USD | 105.31% |
| 2014 | 1.06 Billion USD | 77.64% |
| 2013 | 601.94 Million USD | 29.27% |
| 2012 | 465.63 Million USD | 72.01% |
| 2011 | 270.7 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.77 Billion USD | -1.1% |
| 2024 Q1 | 1.79 Billion USD | 33.65% |
| 2024 Q3 | 1.8 Billion USD | 1.71% |
| 2023 Q3 | 1.45 Billion USD | -1.92% |
| 2023 FY | 1.34 Billion USD | -9.35% |
| 2023 Q1 | 1.51 Billion USD | 2.26% |
| 2023 Q4 | 1.34 Billion USD | -7.72% |
| 2023 Q2 | 1.48 Billion USD | -2.06% |
| 2022 FY | 1.48 Billion USD | -7.18% |
| 2022 Q4 | 1.48 Billion USD | -1.06% |
| 2022 Q3 | 1.49 Billion USD | -0.43% |
| 2022 Q2 | 1.5 Billion USD | -5.12% |
| 2022 Q1 | 1.58 Billion USD | -0.69% |
| 2021 Q2 | 1.53 Billion USD | -2.27% |
| 2021 FY | 1.59 Billion USD | -47.74% |
| 2021 Q1 | 1.56 Billion USD | -48.64% |
| 2021 Q3 | 1.5 Billion USD | -1.89% |
| 2021 Q4 | 1.59 Billion USD | 6.13% |
| 2020 FY | 3.05 Billion USD | -15.38% |
| 2020 Q1 | 3.41 Billion USD | -5.21% |
| 2020 Q3 | 3.54 Billion USD | -0.23% |
| 2020 Q4 | 3.05 Billion USD | -13.87% |
| 2020 Q2 | 3.55 Billion USD | 3.89% |
| 2019 Q3 | 3.61 Billion USD | -2.31% |
| 2019 FY | 3.6 Billion USD | 14.19% |
| 2019 Q1 | 3.72 Billion USD | 17.95% |
| 2019 Q2 | 3.69 Billion USD | -0.77% |
| 2019 Q4 | 3.6 Billion USD | -0.13% |
| 2018 Q2 | 3.18 Billion USD | -0.63% |
| 2018 FY | 3.15 Billion USD | -1.43% |
| 2018 Q3 | 3.18 Billion USD | -0.18% |
| 2018 Q1 | 3.2 Billion USD | 0.09% |
| 2018 Q4 | 3.15 Billion USD | -0.71% |
| 2017 Q2 | 3.24 Billion USD | -0.19% |
| 2017 Q1 | 3.24 Billion USD | -0.2% |
| 2017 Q4 | 3.2 Billion USD | -0.9% |
| 2017 FY | 3.2 Billion USD | -1.47% |
| 2017 Q3 | 3.23 Billion USD | -0.2% |
| 2016 Q3 | 3.58 Billion USD | 0.15% |
| 2016 Q1 | 3.49 Billion USD | 59.31% |
| 2016 FY | 3.25 Billion USD | 48.17% |
| 2016 Q4 | 3.25 Billion USD | -9.23% |
| 2016 Q2 | 3.57 Billion USD | 2.31% |
| 2015 Q1 | 2.01 Billion USD | 88.78% |
| 2015 Q4 | 2.19 Billion USD | 4.93% |
| 2015 Q3 | 2.09 Billion USD | 9.28% |
| 2015 Q2 | 1.91 Billion USD | -5.16% |
| 2015 FY | 2.19 Billion USD | 105.31% |
| 2014 Q3 | 1.01 Billion USD | 82.8% |
| 2014 Q2 | 555.81 Million USD | -14.96% |
| 2014 Q1 | 653.62 Million USD | 8.59% |
| 2014 FY | 1.06 Billion USD | 77.64% |
| 2014 Q4 | 1.06 Billion USD | 5.25% |
| 2013 FY | 601.94 Million USD | 29.27% |
| 2013 Q2 | 556.27 Million USD | -0.68% |
| 2013 Q3 | 571.95 Million USD | 2.82% |
| 2013 Q4 | 601.94 Million USD | 5.24% |
| 2013 Q1 | 560.09 Million USD | 20.29% |
| 2012 Q4 | 465.63 Million USD | 63.59% |
| 2012 FY | 465.63 Million USD | 72.01% |
| 2012 Q3 | 284.63 Million USD | -1.37% |
| 2012 Q2 | 288.57 Million USD | -3.65% |
| 2012 Q1 | 299.51 Million USD | 10.64% |
| 2011 Q3 | 131.37 Million USD | 0.0% |
| 2011 Q4 | 270.7 Million USD | 106.06% |
| 2011 FY | 270.7 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Addus HomeCare Corporation | 124.13 Million USD | -981.549% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -1831.64% |
| Amedisys, Inc. | 346.76 Million USD | -287.167% |
| American Oncology Network, Inc. | 120.44 Million USD | -1014.666% |
| Astrana Health, Inc. | 296.26 Million USD | -353.164% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | -5.187% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -1159.072% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -14364.034% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -50314.87% |
| COMPASS Pathways plc | 28.75 Million USD | -4568.595% |
| DocGo Inc. | 15.16 Million USD | -8754.737% |
| The Ensign Group, Inc. | 1.78 Billion USD | 24.78% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -11849.693% |
| InnovAge Holding Corp. | 100.49 Million USD | -1235.922% |
| Assure Holdings Corp. | 505 Thousand USD | -265751.089% |
| The Joint Corp. | 2 Million USD | -67027.4% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -378.994% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -351869.253% |
| ModivCare Inc. | 983.75 Million USD | -36.472% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -1128290.724% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -76241.212% |
| Option Care Health, Inc. | 1.05 Billion USD | -27.057% |
| P3 Health Partners Inc. | 108.31 Million USD | -1139.439% |
| P3 Health Partners Inc. | 108.31 Million USD | -1139.439% |
| The Pennant Group, Inc. | 312.51 Million USD | -329.602% |
| Surgery Partners, Inc. | 2.03 Billion USD | 33.982% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1446.251% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1446.251% |